Presentation Information
[3S07a-07]Role of LSD1 complex and development of new LSD1 inhibitors in neuroendocrine small-cell lung cancer
○Tomoaki Tanaka1, Shuichi Ohkubo2 (1.Department of Molecular Diagnosis, Graduate School of Medicine, Chiba University, 2.Discovery and Preclinical Research Division, Taiho Pharmaceutical Co., Ltd.)
キーテクノロジー:プロテオミクス
Keywords:
肺がん、LSD1阻害剤、エピジェネティクス
tomoaki@restaff.chiba-u.jp
Password required to view
Comment
To browse or post comments, you must log in.Log in